Abstract
Chronic renal failure (CRF) is characterized by progressive and irreversible loss of renal function and its treatment generates a public expenditure for maintenance of patients on dialysis. The stem cell therapy (CT) may be a promising strategy to repair/slow the progression of CRF. However, there are doubts about the cell type used in the repair and the role of the kidney. Preliminary da…